Concepedia

VHPKQHR peptide modified magnetic mesoporous nanoparticles for MRI detection of atherosclerosis lesions

Wan Xu, Shuihua Zhang, Quan Zhou, Wenli Chen

Artificial Cells Nanomedicine and Biotechnology · 2019 · 33 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

is a superior contrast agent of magnetic resonance imaging (MRI) for diagnosis of atherosclerosis plaques.

References

14

Upregulation of VCAM-1 and ICAM-1 at Atherosclerosis-Prone Sites on the Endothelium in the ApoE-Deficient Mouse

Yutaka Nakashima, Elaine W. Raines, Andrew Plump et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1998 · 913 citations

, , +17

Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis

Matthias Nahrendorf, Farouc A. Jaffer, David E. Sosnovik et al. · Circulation · 2006 · 594 citations · Full text

, , +17

Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy

Wei Yi, Li Gao, Lu Wang et al. · Drug Delivery · 2017 · 160 citations · Full text

, , +17

In Vivo Phage Display Selection Yields Atherosclerotic Plaque Targeted Peptides for Imaging

Matthias Nahrendorf, Amy Yu, Fred Reynolds et al. · Molecular Imaging and Biology · 2006 · 135 citations

, , +10

VCAM‐1‐targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis

Sébastien Serres, Silvy Mardiguian, Sandra J. Campbell et al. · The FASEB Journal · 2011 · 75 citations

, , +17